Junshi Biosciences 君实生物
9 significant filings since 31 May 2026: 3 on major holder selling, 2 on new listing and 2 on change of interest, and 2 other kinds. The latest, on 31 Aug 2026: 君实生物关于股东减持股份计划的公告.
自 31 May 2026 起有 9 份重大公告：major holder selling 3 份、new listing 2 份、change of interest 2 份，另有 2 类。最新一份（31 Aug 2026）：君实生物关于股东减持股份计划的公告。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | -0.39 | 0.06 |
| 7 days ago | -0.39 | 0.06 |
| 30 days ago | 2 brokers | 2 brokers |
| 60 days ago | -0.44 | 0.04 |
| 90 days ago | -0.44 | 0.04 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from -0.15 in Sep 2025 to -0.39 in Sep 2026 (-160.0%). 一致预期从 Sep 2025 的 -0.15 变为 Sep 2026 的 -0.39 (-160.0%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 1 = 0 | ▲ 0 ▼ 1 = 0 |
| Last 90 days | ▲ 0 ▼ 2 = 1 | ▲ 0 ▼ 2 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 0. 惊喜幅度需公告前120天内至少3家券商预测；FY2025仅1家；FY2024仅0家。